米国における処方上の障壁：統合失調症

本レポートでは、統合失調症市場において外部の障壁が処方決定にどのような影響を与えるかを調査し、治療を行う医師への調査データに基づき、コスト、アベイラビリティ、償還、ガイドライン、患者の嗜好といった要因とそれらが治療選択に及ぼす影響を分析しています。調査結果は、特定のブランドを処方している医師あるいは処方していない医師の実態、障壁が処方パターンをどのように形成しているか、競合する治療薬の間での市場シェアの変動を詳細に示しています。

主要な検討課題：

• 1.コスト、アベイラビリティ、患者の嗜好といった外部要因は、ブランドの市場シェアにどのような影響を与えているか？
• 2.誰がブランド薬を処方しているか、誰が処方していないか、どの医師が処方を検討する意向を持っているか？
• 3.医師はどのように治療薬を選択し、どの障壁がその決定に大きな影響を与えているか？
• 4.各種の障壁によって、各ブランドはどの程度市場シェアを獲得または喪失しているか？また、主要な競合は誰か？

主要ブランド

This report examines how external market barriers influence prescribing decisions in the schizophrenia market. Drawing on survey data from treating physicians, it analyzes factors such as cost, availability, reimbursement, guidelines, and patient preferences, and their impact on therapy choice. The findings provide a detailed view of who is and is not prescribing specific brands, how barriers shape prescription patterns, and the resulting shifts in market share between competing therapies.

Key Questions Answered:

• 1. How are external factors such as cost, availability, and patient preferences impacting your brand's market share?
• 2. Who is and isn't prescribing your brand, and which physicians are willing to consider it?
• 3. How do physicians choose therapies and which barriers significantly influence their decisions?
• 4. How much market share does your brand gain or lose due to various barriers and who are the key competitors?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.